PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Exploring Early LDL-C Lowering in Patients With Recent MI to Reduce Future Events
Visit https://www.peervoice.com/XMS860 to view the entire programme with slides. After completing “Exploring Early LDL-C Lowering in Patients With Recent MI to Reduce Future Events”, participants will be able to: Identify patients with recent myocardial infarction (MI) at high risk of cardiovascular (CV) events who may benefit from PCSK-9 inhibitors; Discuss optimal multidisciplinary management of patients following MI, based on the latest evidence and recommendations; Identify the key changes to the CCS 2021 dyslipidemia guidelines with a focus on post myocardial infarction (MI); Apply the new dyslipidemia guidelines to clinical practice in patients with a recent MI.